The GAP Clinical Trials Unit (CTU) has been in existence for over 20 years. Under the leadership of Judith Martin, MD, the team consists of physicians, advanced care providers, research nurse coordinators, regulatory specialist(s), data managers, statisticians and research assistants who are dedicated to conducting high quality pediatric clinical research.
The long-term goal of this unit is to evaluate frequently performed pediatric treatments and procedures that entail substantial use of health care resources but whose value has not been adequately substantiated. Faculty in the division have extensive involvement in clinical research, which have included landmark studies published in high impact journal evaluating pharyngitis, tonsillectomy, tympanostomy tube placement, antibiotics for sinusitis, community-acquired pneumonia, acute otitis media and urinary tract infections.
The research includes studies supported by the Center for Disease Control and Prevention (CDC) on immunogenicity of influenza vaccines since 2013. Funding sources for the GAP CTU include: National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) and National Institute of Child Health and Human Development (NICHD), NIH Vaccine and Treatment Evaluation Units (VTEU); and the Centers for Disease Control and Prevention (CDC). The group is involved in studies in several networks including the New Vaccine Surveillance Network and COVID Prevention Network.
- Alejandro Hoberman, MD - Division Director
- Judith Martin, MD - Clinical Trials Unit Director
- Nader Shaikh, MD, MPH
- Timothy R. Shope, MD, MPH
- Sonika Bhatnagar, MD, MPH, FAAP
- Gysella B. Muniz Pujalt, MD
- Maya I. Ragavan, MD, MPH, MS
- Kristin N. Ray, MD, MS, FAAP
- Stacey Engster, MD, MS
- Anne-Marie Rick, MD, MPH
- Kumaravel Rajakumar, MBBS, MS